On Oct. 29, 2017, Capital Economic Report, a program of Beijing TV Financial Channel, released a feature on the 19th Congress, in which Annoroad was reported as a representative of the high-end and platform enterprises in China’s gene industry.

In the interview, the person in charge of Annoroad mentioned that after the first five-year painstaking development, Annoroad has entered the front echelon of the industry in terms of talent reserve, market share and brand influence. At present, breakthroughs have been made in the major directions including the R&D and manufacturing of high-throughput gene sequencers and related reagents, reproductive gene testing, genetic disease detection, tumor gene testing, genetic test, medical research, scientific research services and gene big data processing, resulting in the whole-industry chain layout covering the upstream, midstream and downstream of the business and the Bio-IT industrial service capacity.

Besides Beijing TV, as a representative of high-end enterprises, Annoroad has attracted the attention of many well-known media in recent years, such as People’s Daily Online, Global Times, Radio Beijing and GenomeWeb. The achievements of Annoroad in gene sequencing have been the topics of their reports.